NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Enlivex Therapeutics Ltd (TA: ENLV)

 
ENLV Technical Analysis
5
As on 12th Jun 2025 ENLV STOCK Price closed @ 326.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 745.24 & Strong Sell for SHORT-TERM with Stoploss of 1043.99 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ENLVSTOCK Price

Open 334.10 Change Price %
High 334.10 1 Day -10.30 -3.06
Low 315.10 1 Week -19.20 -5.56
Close 326.00 1 Month -31.10 -8.71
Volume 13922 1 Year -205.60 -38.68
52 Week High 1581.00 | 52 Week Low 318.50
 
TA Israel Most Active Stocks
TA125 2008.05 1.06%
BLRX 3.10 -6.06%
CANF 1.30 0.00%
ORL 87.80 -2.88%
LUMI 5635.00 -1.61%
BEZQ 540.00 -2.70%
POLI 5693.00 -1.52%
FRSX 6.80 -5.56%
ELAL 1387.00 -1.91%
MGDL 739.70 -1.88%
 
TA Israel Top Gainers Stocks
TDGN-L 171.50 17.55%
MCRNT 372.50 16.84%
CNMD 45.10 10.54%
CNMD 45.10 10.54%
SFET 65.10 8.50%
SFET 65.10 8.50%
SEFA 596.70 5.61%
SEFA 596.70 5.61%
NALA 596.70 5.61%
LEOF 456.80 4.99%
 
TA Israel Top Losers Stocks
KRNV 3.30 -32.65%
KMNK 51.00 -23.19%
MCTC 66.00 -22.35%
ALMO 915.00 -20.92%
NXTG 69.20 -18.59%
ULTR 74.10 -16.74%
EVGN 550.00 -16.30%
EVGN 550.00 -16.30%
EVGN 550.00 -16.30%
TEDE 451.70 -12.29%
 
 
ENLV
Daily Charts
ENLV
Intraday Charts
Whats New @
Bazaartrend
ENLV
Free Analysis
 
ENLV Important Levels Intraday
RESISTANCE362.61
RESISTANCE350.87
RESISTANCE343.61
RESISTANCE336.36
SUPPORT315.65
SUPPORT308.39
SUPPORT301.13
SUPPORT289.39
 
ENLV Forecast June 2025
4th UP Forecast1328.04
3rd UP Forecast1006.68
2nd UP Forecast808.04
1st UP Forecast609.4
1st DOWN Forecast42.6
2nd DOWN Forecast-156.04
3rd DOWN Forecast-354.68
4th DOWN Forecast-676.04
 
ENLV Weekly Forecast
4th UP Forecast647.81
3rd UP Forecast544.60
2nd UP Forecast480.81
1st UP Forecast417.02
1st DOWN Forecast234.99
2nd DOWN Forecast171.19
3rd DOWN Forecast107.40
4th DOWN Forecast4.19
 
ENLV Forecast2025
4th UP Forecast2813.18
3rd UP Forecast2015.53
2nd UP Forecast1522.48
1st UP Forecast1029.43
1st DOWN Forecast-377.43
2nd DOWN Forecast-870.48
3rd DOWN Forecast-1363.53
4th DOWN Forecast-2161.18
 
 
ENLV Other Details
Segment EQ
Market Capital 50720083968.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ENLV Address
ENLV
 
ENLV Latest News
 
Your Comments and Response on Enlivex Therapeutics Ltd
 
ENLV Business Profile
Enlivex Therapeutics Ltd. operates as a clinical stage immunotherapy company. It is developing Allocetra, an off-the-shelf cell therapy designed to reprogram macrophages into homeostatic state. Resetting non-homeostatic macrophages into homeostatic state is critical for immune system rebalancing and resolution of life-threatening conditions. Diseases, such as solid cancers, sepsis, COVID-19, and others reprogram macrophages out of homeostatic state. Its Allocetra has the potential to provide a novel immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents. The company has a research collaboration with Yale Cancer Center for the assessment of Allocetra to enhance the activity of checkpoint inhibitors in solid tumors. Enlivex Therapeutics Ltd. was incorporated in 2005 and is headquartered in Nes Ziona, Israel. Address: 14 Einstein Street, Ness Ziona, Israel, 7403618
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service